Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

A patient's skin rash did not affect the area where a previous viral rash was healing, suggesting a rare immune response.

Older skin has higher cancer risk due to inflammation and stem cell issues.

Platelet-rich plasma (PRP) speeds up skin wound healing and has potential in medical and cosmetic uses.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

Biotin supplementation during isotretinoin treatment for acne may help maintain skin hydration and improve hair growth.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Artificial hair implants can quickly improve looks and life quality, but they have risks like infection and early fiber loss, so more research is needed to confirm their safety and effectiveness.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Mesotherapy is a minimally invasive treatment with potential benefits and risks, requiring standardized practices and further investigation.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

The review suggests that a special cell-derived treatment shows promise for various skin conditions and hair growth but needs more research for confirmation.

Oral isotretinoin may slightly improve acne but increases the risk of side effects like dry lips and skin; more research is needed to understand its full risks and benefits.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

No single treatment is clearly effective for central serous chorioretinopathy.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

Most skin rashes in rheumatoid arthritis patients were not caused by their medication, and careful evaluation allowed most to keep taking their beneficial treatment.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.